Advertisement

Topics

FDA approves Vyxeos for acute myeloid leukemia

14:38 EDT 4 Aug 2017 | Drug Store News

Vyxeos combines two commonly used chemotherapies into a single formulation to treat patients with certain types of high-risk acute myeloid leukemia

read more

Original Article: FDA approves Vyxeos for acute myeloid leukemia

NEXT ARTICLE

More From BioPortfolio on "FDA approves Vyxeos for acute myeloid leukemia"

Quick Search
Advertisement